Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition
NCT01735370
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Fasting
Interventions
DRUG:
Etodolac Tablets USP 500mg
DRUG:
Etodolac Tablets USP 500 mg
Sponsor
IPCA Laboratories Ltd.